1. Home
  2. CTSO
  3. CTSO News

Latest Cytosorbents Corporation (CTSO) News on April 19, 2025

CytoSorbents Appoints Melanie Grossman, CPA as Vice President and Corporate Controller
CTSO

PR Newswire

2 days ago

CytoSorbents Appoints Melanie Grossman, CPA as Vice President and Corporate Controller

CytoSorbents Appoints Thomas Shannon as Vice President of Marketing for North America
CTSO

PR Newswire

5 days ago

CytoSorbents Appoints Thomas Shannon as Vice President of Marketing for North America

CytoSorbents Extends Expiration Date of Outstanding Series B Right Warrants
CTSO

PR Newswire

15 days ago

CytoSorbents Extends Expiration Date of Outstanding Series B Right Warrants

CTSO

Zacks Small Cap Research

15 days ago

CTSO: CytoSorbents Reports 4th quarter and 2024 Financial Results Which Showed Impressive Product Revenue Growth That Exceeded Our Expectations.

CTSO

Thomson Reuters StreetEvents

18 days ago

Q4 2024 Cytosorbents Corp Earnings Call

CytoSorbents Corp (CTSO) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ...
CTSO

GuruFocus.com

18 days ago

CytoSorbents Corp (CTSO) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ...

CTSO

Associated Press Finance

19 days ago

CytoSorbents: Q4 Earnings Snapshot

CytoSorbents Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights
CTSO

PR Newswire

19 days ago

CytoSorbents Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights

CytoSorbents Corp (CTSO) Q4 2024 Earnings Report Preview: What to Look For
CTSO

GuruFocus.com

a month ago

CytoSorbents Corp (CTSO) Q4 2024 Earnings Report Preview: What to Look For

CytoSorbents Reschedules Earnings Release to March 31, 2025 to Allow Additional Time to Complete Annual Audit
CTSO

PR Newswire

a month ago

CytoSorbents Reschedules Earnings Release to March 31, 2025 to Allow Additional Time to Complete Annual Audit

Cytosorbents (NASDAQ:CTSO) shareholders have endured a 78% loss from investing in the stock five years ago
CTSO

Simply Wall St.

a month ago

Cytosorbents (NASDAQ:CTSO) shareholders have endured a 78% loss from investing in the stock five years ago

CytoSorbents Corp (CTSO) Q4 2024 Earnings Report Preview: What To Expect
CTSO

GuruFocus.com

a month ago

CytoSorbents Corp (CTSO) Q4 2024 Earnings Report Preview: What To Expect

CytoSorbents Postpones Earnings Release to Allow More Time to Complete Annual Audit Following the Passing of Corporate Controller
CTSO

GlobeNewswire

2 months ago

CytoSorbents Postpones Earnings Release to Allow More Time to Complete Annual Audit Following the Passing of Corporate Controller

CytoSorbents to Report Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights
CTSO

GlobeNewswire

2 months ago

CytoSorbents to Report Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights

CytoSorbents Further Strengthens Balance Sheet with Exercise of Previously Announced Series A Right Warrants
CTSO

GlobeNewswire

2 months ago

CytoSorbents Further Strengthens Balance Sheet with Exercise of Previously Announced Series A Right Warrants

Cytosorbents Boosts Liquidity with Successful Rights Offering
CTSO

TipRanks

3 months ago

Cytosorbents Boosts Liquidity with Successful Rights Offering

CytoSorbents Strengthens Balance Sheet with Closing of Oversubscribed Rights Offering
CTSO

GlobeNewswire

3 months ago

CytoSorbents Strengthens Balance Sheet with Closing of Oversubscribed Rights Offering

CytoSorbents Expands Global Footprint with Opening of New Regional Sales Subsidiary in Dubai
CTSO

GlobeNewswire

3 months ago

CytoSorbents Expands Global Footprint with Opening of New Regional Sales Subsidiary in Dubai

CytoSorbents reported strong Q4 results, says D. Boral Capital
CTSO

TipRanks

3 months ago

CytoSorbents reported strong Q4 results, says D. Boral Capital

CTSO

Zacks Small Cap Research

4 months ago

CTSO: CytoSorbents Reports Preliminary 4th Quarter and 2024 Financial Results Which Showed Impressive Product Revenue Growth That Exceeded Our Expectations.

CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2024 Product Revenue
CTSO

GlobeNewswire

4 months ago

CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2024 Product Revenue

CytoSorbents Rights Offering Begins
CTSO

GlobeNewswire

4 months ago

CytoSorbents Rights Offering Begins

CytoSorbents to Host Investor Meetings in San Francisco During J.P. Morgan Healthcare Conference Week
CTSO

GlobeNewswire

4 months ago

CytoSorbents to Host Investor Meetings in San Francisco During J.P. Morgan Healthcare Conference Week

CTSO

Zacks Small Cap Research

4 months ago

CTSO: CytoSorbents Announces Rights Offering Which has the Potential to Substantially Increase Available Liquidity

CytoSorbents Announces Rights Offering
CTSO

GlobeNewswire

4 months ago

CytoSorbents Announces Rights Offering

CytoSorbents to Participate at the Piper Sandler 36th Annual Healthcare Conference
CTSO

GlobeNewswire

5 months ago

CytoSorbents to Participate at the Piper Sandler 36th Annual Healthcare Conference

CTSO

Zacks Small Cap Research

5 months ago

CTSO: CytoSorbents Potential for High Margin Revenue Growth Supports Price Target of $4.00

Several Insiders Invested In Cytosorbents Flagging Positive News
CTSO

Simply Wall St.

5 months ago

Several Insiders Invested In Cytosorbents Flagging Positive News

CytoSorbents And Converge Biotech Announce Strategic Partnership to Expand Sepsis and Critical Care Treatment with CytoSorb in India
CTSO

GlobeNewswire

5 months ago

CytoSorbents And Converge Biotech Announce Strategic Partnership to Expand Sepsis and Critical Care Treatment with CytoSorb in India

CytoSorbents Corp (CTSO) Q3 2024 Earnings Call Highlights: Strong Sales Growth and Improved ...
CTSO

GuruFocus.com

5 months ago

CytoSorbents Corp (CTSO) Q3 2024 Earnings Call Highlights: Strong Sales Growth and Improved ...

CTSO

Associated Press Finance

5 months ago

CytoSorbents: Q3 Earnings Snapshot

CytoSorbents Reports Third Quarter 2024 Financial and Operational Results
CTSO

GlobeNewswire

5 months ago

CytoSorbents Reports Third Quarter 2024 Financial and Operational Results

CytoSorbents Corp (CTSO) Q3 2024: Everything You Need to Know Ahead of Earnings
CTSO

GuruFocus.com

5 months ago

CytoSorbents Corp (CTSO) Q3 2024: Everything You Need to Know Ahead of Earnings

CytoSorbents Submits Health Canada Medical Device License Application for DrugSorb-ATR Following MDSAP Certification
CTSO

GlobeNewswire

5 months ago

CytoSorbents Submits Health Canada Medical Device License Application for DrugSorb-ATR Following MDSAP Certification

FDA Accepts DrugSorb-ATR De Novo Application To Reduce the Severity of CABG-Related Bleeding Due to Ticagrelor and Initiates Substantive Review
CTSO

GlobeNewswire

6 months ago

FDA Accepts DrugSorb-ATR De Novo Application To Reduce the Severity of CABG-Related Bleeding Due to Ticagrelor and Initiates Substantive Review

CytoSorbents to Report Third Quarter 2024 Operating and Financial Results
CTSO

GlobeNewswire

6 months ago

CytoSorbents to Report Third Quarter 2024 Operating and Financial Results

CytoSorbents Corp (CTSO) Q2 2024 Earnings Call Highlights: Revenue Growth and Strategic ...
CTSO

GuruFocus.com

6 months ago

CytoSorbents Corp (CTSO) Q2 2024 Earnings Call Highlights: Revenue Growth and Strategic ...

CTSO

Zacks Small Cap Research

7 months ago

CTSO: CytoSorbents Announces Submission of DrugSorb-ATR Application to the FDA

CytoSorbents Submits DrugSorb-ATR Marketing Application to U.S. FDA to Reduce the Severity of Bleeding in Heart Bypass Surgery Patients on the Blood Thinner Ticagrelor and Provides Business Update
CTSO

GlobeNewswire

7 months ago

CytoSorbents Submits DrugSorb-ATR Marketing Application to U.S. FDA to Reduce the Severity of Bleeding in Heart Bypass Surgery Patients on the Blood Thinner Ticagrelor and Provides Business Update

Cytosorbents (NASDAQ:CTSO) shareholders have endured a 81% loss from investing in the stock three years ago
CTSO

Simply Wall St.

7 months ago

Cytosorbents (NASDAQ:CTSO) shareholders have endured a 81% loss from investing in the stock three years ago

CTSO

Zacks Small Cap Research

7 months ago

CTSO: CytoSorbents Potential for High Margin Revenue Growth Supports Price Target of $4.00

CytoSorbents to Present at the H.C. Wainwright 26ᵗʰ Annual Global Investment Conference
CTSO

GlobeNewswire

8 months ago

CytoSorbents to Present at the H.C. Wainwright 26ᵗʰ Annual Global Investment Conference

CytoSorbents Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CTSO

GlobeNewswire

8 months ago

CytoSorbents Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CTSO

Associated Press Finance

8 months ago

CytoSorbents: Q2 Earnings Snapshot

CytoSorbents Reports Second Quarter 2024 Financial and Operational Results
CTSO

GlobeNewswire

8 months ago

CytoSorbents Reports Second Quarter 2024 Financial and Operational Results

CytoSorbents Appoints Peter J. Mariani Chief Financial Officer
CTSO

GlobeNewswire

8 months ago

CytoSorbents Appoints Peter J. Mariani Chief Financial Officer

CytoSorbents to Report Second Quarter 2024 Operating and Financial Results
CTSO

GlobeNewswire

8 months ago

CytoSorbents to Report Second Quarter 2024 Operating and Financial Results

CytoSorbents Announces Compliance with Nasdaq Minimum Bid Price Requirement
CTSO

GlobeNewswire

9 months ago

CytoSorbents Announces Compliance with Nasdaq Minimum Bid Price Requirement

CytoSorbents Unveils Newly Redesigned, Unified Company and Product Website
CTSO

GlobeNewswire

9 months ago

CytoSorbents Unveils Newly Redesigned, Unified Company and Product Website

CytoSorbents Unveils Newly Redesigned, Unified Company and Product Website
CTSO

GlobeNewswire

9 months ago

CytoSorbents Unveils Newly Redesigned, Unified Company and Product Website

CytoSorbents to Present at the Inaugural American Association of Physicians of Indian Origin (AAPI) World Health Congress
CTSO

GlobeNewswire

9 months ago

CytoSorbents to Present at the Inaugural American Association of Physicians of Indian Origin (AAPI) World Health Congress

CytoSorbents Secures $20 Million Credit Facility
CTSO

GlobeNewswire

10 months ago

CytoSorbents Secures $20 Million Credit Facility

CTSO

MT Newswires

10 months ago

CytoSorbents' Blood Purification Device Gets Approval in Taiwan

CytoSorbents Announces Regulatory Approval of CytoSorb® in Taiwan
CTSO

GlobeNewswire

10 months ago

CytoSorbents Announces Regulatory Approval of CytoSorb® in Taiwan

CytoSorbents Announces the Launch and Immediate Availability of the PuriFi™ Blood Pump in the European Union
CTSO

GlobeNewswire

10 months ago

CytoSorbents Announces the Launch and Immediate Availability of the PuriFi™ Blood Pump in the European Union

Edge Total Intelligence Inc. Updates Status of MCTO
CTSO

Newsfile

10 months ago

Edge Total Intelligence Inc. Updates Status of MCTO

The sale of Aspo's subsidiary ESL Shipping's Supramax vessels has been completed on June 11 2024
CTSO

GlobeNewswire

10 months ago

The sale of Aspo's subsidiary ESL Shipping's Supramax vessels has been completed on June 11 2024

Hyundai Motor Presents Its First Film 'Night Fishing' in Collaboration with K-Movie Star Son Sukku
CTSO

CNW Group

10 months ago

Hyundai Motor Presents Its First Film 'Night Fishing' in Collaboration with K-Movie Star Son Sukku

Nokia introduces Network Exposure Platform to expand and simplify network API exposure for service providers
CTSO

GlobeNewswire

10 months ago

Nokia introduces Network Exposure Platform to expand and simplify network API exposure for service providers

HEATHERWICK STUDIO UNVEILS ICONIC GLASS CANOPY, THE JEWEL IN THE CROWN OF REIMAGINED OLYMPIA
CTSO

CNW Group

10 months ago

HEATHERWICK STUDIO UNVEILS ICONIC GLASS CANOPY, THE JEWEL IN THE CROWN OF REIMAGINED OLYMPIA

LED Driver with CAN Bus for Dynamic Automotive Interior RGB Lighting
CTSO

GlobeNewswire

10 months ago

LED Driver with CAN Bus for Dynamic Automotive Interior RGB Lighting

Hofseth Biocare ASA: AGREES CHINA DISTRIBUTION PARTNERSHIP WITH SHANGHAI-BASED LITHY
CTSO

GlobeNewswire

10 months ago

Hofseth Biocare ASA: AGREES CHINA DISTRIBUTION PARTNERSHIP WITH SHANGHAI-BASED LITHY

IMAGO AIOS Prime Clinches Red Dot Award for 2024, Expands US Footprint with New Boston Warehouse
CTSO

PR Newswire

10 months ago

IMAGO AIOS Prime Clinches Red Dot Award for 2024, Expands US Footprint with New Boston Warehouse

CytoSorbents to Host its 2024 Virtual Annual Stockholders Meeting
CTSO

GlobeNewswire

10 months ago

CytoSorbents to Host its 2024 Virtual Annual Stockholders Meeting

CytoSorbents STAR Registry Data on Patients on Ticagrelor Undergoing CABG Surgery with CytoSorb Presented at EuroPCR 2024. Named Top Five Finalist for Best Scientific Abstract
CTSO

GlobeNewswire

10 months ago

CytoSorbents STAR Registry Data on Patients on Ticagrelor Undergoing CABG Surgery with CytoSorb Presented at EuroPCR 2024. Named Top Five Finalist for Best Scientific Abstract

Here's Why Shareholders Should Examine Cytosorbents Corporation's (NASDAQ:CTSO) CEO Compensation Package More Closely
CTSO

Simply Wall St.

a year ago

Here's Why Shareholders Should Examine Cytosorbents Corporation's (NASDAQ:CTSO) CEO Compensation Package More Closely

CTSO

Zacks Small Cap Research

a year ago

CTSO: CytoSorbents Potential for High Margin Revenue Growth Supports Price Target of $4.00

Cytosorbents First Quarter 2024 Earnings: In Line With Expectations
CTSO

Simply Wall St.

a year ago

Cytosorbents First Quarter 2024 Earnings: In Line With Expectations

Cytosorbents Corporation (NASDAQ:CTSO) Q1 2024 Earnings Call Transcript
CTSO

Insider Monkey

a year ago

Cytosorbents Corporation (NASDAQ:CTSO) Q1 2024 Earnings Call Transcript

CTSO

Associated Press Finance

a year ago

CytoSorbents: Q1 Earnings Snapshot

CytoSorbents Reports First Quarter 2024 Results
CTSO

GlobeNewswire

a year ago

CytoSorbents Reports First Quarter 2024 Results

CytoSorbents May 6, 2024 Virtual KOL and Analyst-Investor Day: STAR-T Pivotal Trial Topline Results & Real World Experience with Antithrombotic Drug Removal in Europe
CTSO

GlobeNewswire

a year ago

CytoSorbents May 6, 2024 Virtual KOL and Analyst-Investor Day: STAR-T Pivotal Trial Topline Results & Real World Experience with Antithrombotic Drug Removal in Europe

CytoSorbents to Report First Quarter 2024 Operating and Financial Results
CTSO

GlobeNewswire

a year ago

CytoSorbents to Report First Quarter 2024 Operating and Financial Results

STAR-T Pivotal Trial Results to Be Featured as a Late-Breaking Presentation at the 2024 American Association for Thoracic Surgery Annual Meeting
CTSO

GlobeNewswire

a year ago

STAR-T Pivotal Trial Results to Be Featured as a Late-Breaking Presentation at the 2024 American Association for Thoracic Surgery Annual Meeting

CTSO

Zacks Small Cap Research

a year ago

CTSO: CytoSorbents Expects Significant Gross Margin Expansion in 2023.

These Analysts Think Cytosorbents Corporation's (NASDAQ:CTSO) Sales Are Under Threat
CTSO

Simply Wall St.

a year ago

These Analysts Think Cytosorbents Corporation's (NASDAQ:CTSO) Sales Are Under Threat

Cytosorbents Full Year 2023 Earnings: Misses Expectations
CTSO

Simply Wall St.

a year ago

Cytosorbents Full Year 2023 Earnings: Misses Expectations

Cytosorbents Corporation (NASDAQ:CTSO) Q4 2023 Earnings Call Transcript
CTSO

Insider Monkey

a year ago

Cytosorbents Corporation (NASDAQ:CTSO) Q4 2023 Earnings Call Transcript

CTSO

Thomson Reuters StreetEvents

a year ago

Q4 2023 Cytosorbents Corp Earnings Call

CytoSorbents Reports Fourth Quarter and Full Year 2023 Results
CTSO

GlobeNewswire

a year ago

CytoSorbents Reports Fourth Quarter and Full Year 2023 Results

CytoSorbents to Report Fiscal 2023 Operating and Financial Results
CTSO

GlobeNewswire

a year ago

CytoSorbents to Report Fiscal 2023 Operating and Financial Results

Cytosorbents (NASDAQ:CTSO) investors are sitting on a loss of 90% if they invested three years ago
CTSO

Simply Wall St.

a year ago

Cytosorbents (NASDAQ:CTSO) investors are sitting on a loss of 90% if they invested three years ago

CytoSorbents to Present at the TD Cowen 44th Annual Health Care Conference
CTSO

GlobeNewswire

a year ago

CytoSorbents to Present at the TD Cowen 44th Annual Health Care Conference

Private Capital Bolsters Stake in Motorcar Parts of America Inc
CTSO

GuruFocus.com

a year ago

Private Capital Bolsters Stake in Motorcar Parts of America Inc

Semper Paratus Acquisition Corporation’s Shareholders Approve Business Combination with Tevogen Bio
CTSO

GlobeNewswire

a year ago

Semper Paratus Acquisition Corporation’s Shareholders Approve Business Combination with Tevogen Bio

CTSO

Newsfile

a year ago

FingerMotion, Inc. Announces Participation in The Microcap Conference

FingerMotion Announces Preliminary Director’s Approval of Dividend Warrant on Terms to be Fixed by Further Resolution of the Board of Directors
CTSO

ACCESSWIRE

a year ago

FingerMotion Announces Preliminary Director’s Approval of Dividend Warrant on Terms to be Fixed by Further Resolution of the Board of Directors

FingerMotion Provides Supplemental Quarterly Guidance
CTSO

ACCESSWIRE

a year ago

FingerMotion Provides Supplemental Quarterly Guidance

Dave Inc.'s (NASDAQ:DAVE) market cap up US$26m last week, benefiting both retail investors who own 41% as well as insiders
CTSO

Simply Wall St.

a year ago

Dave Inc.'s (NASDAQ:DAVE) market cap up US$26m last week, benefiting both retail investors who own 41% as well as insiders

ACNB (ACNB) Surges 6.5%: Is This an Indication of Further Gains?
CTSO

Zacks

a year ago

ACNB (ACNB) Surges 6.5%: Is This an Indication of Further Gains?

CTSO

Zacks Small Cap Research

a year ago

CTSO: CytoSorbents reports update on data results from important U.S. and Canadian STAR-T pivotal trial.

Groundbreaking Randomized Controlled Trial Reports Excellent Clinical Outcomes Using CytoSorb® Intraoperatively in Heart Transplant Patients
CTSO

GlobeNewswire

a year ago

Groundbreaking Randomized Controlled Trial Reports Excellent Clinical Outcomes Using CytoSorb® Intraoperatively in Heart Transplant Patients

Fury Intercepts 31.77 g/t gold and 8.07 g/t Tellurium over 3.5 metres at the Hinge Target
CTSO

ACCESSWIRE

a year ago

Fury Intercepts 31.77 g/t gold and 8.07 g/t Tellurium over 3.5 metres at the Hinge Target

Universal Stainless Business Update Call and Webcast Scheduled for January 24th; Company to Report Fourth Quarter and Full Year 2023 Results in March
CTSO

GlobeNewswire

a year ago

Universal Stainless Business Update Call and Webcast Scheduled for January 24th; Company to Report Fourth Quarter and Full Year 2023 Results in March

Aisera & Dave Launch DaveGPT, a Generative AI Customer Service Assistant to Enable Personalized On-Demand Support
CTSO

PR Newswire

a year ago

Aisera & Dave Launch DaveGPT, a Generative AI Customer Service Assistant to Enable Personalized On-Demand Support

Sidoti Events, LLC's Virtual January Micro-Cap Conference
CTSO

ACCESSWIRE

a year ago

Sidoti Events, LLC's Virtual January Micro-Cap Conference

4 Solid Profitable Stocks to Buy Using Net Income Ratio
CTSO

Zacks

a year ago

4 Solid Profitable Stocks to Buy Using Net Income Ratio

HOOKIPA Pharma Appoints Mark Winderlich as Chief Development Officer to Lead Clinical Research and Development Organization
CTSO

GlobeNewswire

a year ago

HOOKIPA Pharma Appoints Mark Winderlich as Chief Development Officer to Lead Clinical Research and Development Organization

The Joint Corp. Reports 2023 Operating Metrics
CTSO

GlobeNewswire

a year ago

The Joint Corp. Reports 2023 Operating Metrics

Fury Reviews 2023 Achievements and Appoints CFO
CTSO

ACCESSWIRE

a year ago

Fury Reviews 2023 Achievements and Appoints CFO

Share on Social Networks: